New pharmaceutical protection against RSV, a virus potentially dangerous for infants and the elderly, has provided a global sales boost for the companies that won regulatory approval.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/kv72umd
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment